chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Female who presents to the office today stating last Thursday on 2/25/2021 she received her first Covid vaccine which was Pfizer. She reports premedicating herself before the vaccination with 1 Pepcid and 2 Benadryl.  However unfortunately within 13 minutes of receiving the vaccine she started to experience a and irritation of the tongue/throat with tingling sensation followed by throat hoarseness, a cough and a red face.  She was experiencing a little bit of chest tightness in addition to a little bit of shortness of breath and therefore used her albuterol inhaler.  Shortly thereafter her red face improved.  EMS was called to the scene however by the time they arrived she was improving and was sent home.  She took a Benadryl at home later in the evening and the following day on Friday she started Pepcid daily since that time. She states since the vaccine she has felt poorly describing exhaustion and feeling achy all over with continued raw throat.  She has not warranted use of her albuterol inhaler since last Thursday and ran out of Benadryl Thursday evening only utilizing Pepcid daily and continues on her other medications. She reports a history of allergies to petroleum products including polyethylene glycol which is suspected to be the cause of her allergic reaction
Patient reports that she was starting to have headache and outbreak of rash like hives later in the afternoon on day of vaccine 01/11/22). Pt. reports leaving work early and went home. Reports that the rash continued for two days so patient went to clinic this a.m. (01/13/2022) and was instructed by provider of care to contact clinic where patient received vaccine and have report sent to VAERS.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: FJY989) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), as dose 3 (booster), single (Lot number: 033h21a) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Dairy" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Gluten, reaction(s): "Known allergies: Gluten". The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", SUSPECTED COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown result; (13Jun2022) negative. Therapeutic measures were taken as a result of suspected covid-19 included Paxlovid.  Clinical information: No other medication in 2weeks. Adverse event description: Experienced Covid-19 rebound 3 days after finishing 5 day regiment of Paxlovid. Testing negative 13Jun2022, however feeling extremely fatigued, brain fog. My wife contracted Covid-19 4 days after my infection. She too took Paxlovid, experienced rebound similar to myself and was still fighting virus. Anti-viral details: product: COVID 19 treatment, brand: Paxlovid, treatment start date: 19May2022, treatment stop date: 23May2022, indication: treatment of COVID-19.
Fifteen minutes after injection Dr. started complaining of nausea, right-sided neck and arm pain described as being hit in the head with a baseball bat.  Then his hand swelled with severe redness and fingers very swollen too.  Dr. then took a Singular and an Ibuprofen.
This spontaneous report was received from a pharmacist concerning a 30 year old female patient. The patient's concurrent conditions and medical history were not reported. On 28-OCT-2015, the patient was vaccinated with an expired dose of PROQUAD (Merck), subcutaneously, lot # K005885, expiration date: 24-OCT-2015, (dose and frequency were not reported) in the left upper arm. Co-suspect therapies or concomitant medications were not provided. The pharmacist reported that the patient just got it and felt fine. It was unknown if there was any relevant laboratory data. At the time of the report it was unknown if the patient would receive another PROQUAD (Merck) injection. No adverse symptoms reported. No product quality complaint was involved. Additional information has been requested.
Vaccination site left deltoid painful, redness and fever tx with ALEVE and ice packs.
lt arm swelled 2 times nl size-heaviness, restless during noc, fever, h/a, all over lousy feeling, loss of appetite & very painful lt arm;Md arm still quit swollen & weak & not nl self;
Feeling real sluggish; Really sick; Nauseated; Diarrhea; feel hot; clammy; throwing up/Vomited; weak; Left arm is a little sore; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution injection; Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 16Feb2021 at 14:00 (at the age of 69-years-old) as single dose for covid-19 immunisation. Medical history included type 1 diabetes mellitus in 2010, atrial fibrillation from 2016 and open heart surgery in 2016. Patient had no known allergies. There were no concomitant medications. Patient did not receive any other vaccinations within four weeks prior to the first administration date of the covid vaccine. Caller stated that her left arm is a little sore but she was fine otherwise until 17Feb2021 around 17:00, at that time she got really sick, nauseated, vomited a little, had diarrhea, and was feeling real sluggish. She began to feel hot, weak, clammy and was throwing up. She asked if these are expected side effects from the vaccine. The patient underwent lab tests and procedures which included blood glucose and blood pressure measurement which was fine. The outcome of the event left arm is a little sore was not recovered while the outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
SIRVA left arm, Unable to lift arm and has pain deltoid and numbness/tingling in arm and hand Narrative:  Sent to PT for further evaluation and treatment
Information has been received from a registered nurse referring to unknown number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of PROQUAD (Merck) (lot # L041629 with expiration date: 22-APR-2017, lot# L041626 with expiration date: 20-APR-2017; lot# L051101 with expiration date: 17-JUN-2017; lot# L050907 with expiration date: 14-JUN-2017, dose was unknown) which were improperly stored (42.3 Fahrenheit (F) for 2 hours 15 minutes). No adverse events were reported. Previous temperature was not excursion. This is one of several reports received from the same reporter. Additional information has been requested.
This report describes hair loss in a 44 y.o. female who was vaccinated with Hep B vaccine recombinant (Engerix-B) for prophylaxis. The subject's medical history included allergy to ampicillin. Concurrent medications were not specified. The subject had not experienced any adverse events following previous immunizations. On 6/3/02, the subject received her first injection of Engerix-B. By approximately 6/10/02, she experienced hair loss, skin itching, and fatigue. The events "came on gradually." The subject was seen by a physician. The Engerix-B immunization series was discontinued. As of 10/8/02, the events has "improved".
This case was reported by a physician via call center representative and described the occurrence of general body pain in a 59-year-old female patient who received SHINGRIX for prophylaxis. In April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In April 2018, less than a year after receiving SHINGRIX, the patient experienced general body pain and fever. On an unknown date, the outcome of the general body pain and fever were not recovered/not resolved. It was unknown if the reporter considered the general body pain and fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. For further tolerance, refer case US2018GSK135599.
Patient experienced itchy, welt-like hives. Her physician's MA described them as looking like "blood blisters." This reaction began the day after receiving the vaccine on 8/11/21. She saw her physician on 8/18/21 because her condition had not resolved. Her physician advised OTC Benadryl to relieve itching. As of today (8/23/21), she describes the hives as "almost gone."
About 9 days after the vaccine,  my left arm swelled up, huge lump size sticking out of my left arm.
Over upper injection site and lower injection site is a 11 cm wide x 8cm high erythematous flare. Complaints of tenderness with palpation over injection site
pt recv vax 5SEP97 & on 10SEP97 pt exp losing balance & falling excessively;
Had the typical symptoms from Moderna 2nd short, 18 hours of aches, headache, fever, chills.  After about 5 days noticed Covid Arm, which I had with first shot but no other symptoms.   About a month after that, mid April, I experienced an outbreak of Herpes Simplex accompanied by swollen lips, upper and lower, and a burning sensation on the inside ridge of my mouth and discomfort on the outside.  This lasted about 10 days during which time I took a round of Acyclovir 200 mg which I have kept current with me over the last 35 years. The sensation subsided, and now returned again with another outbreak of Herpes as of week of May 17. 2021.
Shot given 10:10 am.. While resting at 2:20 pm became aware of "racing heart".    Heart rate maintained 118 - 116 - 114 - 118 - 133  for about 2 hours.  Then 1 hour after that  it was in his normal range of 69 - 74.  Patient cancelled going to work that evening  at 3 pm as he did not want to be on highway with rapid heart rate.  At 4 pm we had a call from our daughter who reported that a friend of hers who had covid  also had this reaction after receiving her #1svaccine.   Patient was covid positive in Dec and was quite ill.
fall; inflammation; This is a spontaneous report from a contactable consumer or other non-HCP (patient reported for himself). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), via an unspecified route of administration on an unspecified date (Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported stating he was scheduled to receive his second dose of the vaccine on 13Aug2021. He received a steroid shot, he thinks for inflammation, on 08Aug2021 from a fall he had. The patient wanted to know if the steroid shot will affect the vaccine. The outcome of the events was unknown at the time of this report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Injection given on 12/28/20 - no adverse events and no issues yesterday; Death today, 12/30/20, approx.. 2am today  (unknown if related - Administrator marked as natural causes)
Woke up with problems breathing, tightness in chest, sore throat, muscle aches, slight fever, chills. Called doctor and went to internist who ran influenza, swine and strep test all negative and breathing test. Told to treat like flu with Tylenol and rest.
Sudden onset tingling to face and head then intense heat with redness to face/ears. Rash to neck throat chest and arms. Hives to arms and back with itchiness.
Case number PHEH2014US020771, is an initial spontaneous report received from a pharmacist on 14 OCT 2014. This report refers to a 46 year old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN 2014/2015 (batch number: 145204) on 09 OCT 2014. Pharmacist reported that two needles after attaching to the top of the syringe snapped off and a small amount of vaccine leaked on her skin. No adverse event was reported. No further information was provided.
Got the shot, then shingles/suspected vaccination failure; Shingles, mild case; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 2-Nov-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the shot and then got shingles but a mild case. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
COVID-19 symptoms started 06/10/22; tested positive on 06/15/22. I thought I had a head cold because of stuffy nose, headache, excessive tiredness, and I developed a sinus infection and went to the Doctor. It lingered on and I couldn't get over it so I did a home test which was positive. I had excessive tiredness and that as it. Symptoms lasted for 2 weeks.
Headache, Fever & NauseaVomiting Narrative:  fever/chills, headache, nausea for 3 days after injection
I was totally fine after the vaccination, just had pain in my arm for two days. After 8 days of vaccination, there was swelling and redness in the vaccination area along with itchiness, and my arm started hurting again. The swelling and redness lasted for 5-6 days, but I still feel the pain if I do much work.
Soreness to upper arm, armpit -> across breast with dizziness & pain with deep breath.
Patient began itching all over after receiving vaccine. Benadryl 50mg administered IVP.  Patient felt better. Refused transport to ER.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-NOV-2015 the patient was vaccinated with an improperly stored dose of GARDASIL (lot K016966, expiration date 10-MAY-2017, dose and route not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 48 hours, the lowest recorded temperature was 34 Fahrenheit degree and the type of excursion was refrigerator (R). The storage criteria was R. This is one of several reports received form the same source. Additional information has been requested.
anaplyaxis: hives, swelling in face, eyelids, throat, low grade fever, increase heart rate
first dose on 11/3/2021. I forgot to get my second; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose on 3rd November 2021).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK receipt date: 13-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had his/her first dose, clearly he/she forgot to get second dose within 6 months. The patient asked what to do. Additional Supportive Information: Till the time of reporting the patient did not received 2nd dose which led to incomplete course of vaccination.
Chills; body aches; headaches; 05/21/2021 all day. Diarrhea, 05/22/2021, a couple of hours.
She had redness and swelling starting the day of the injection no fever, limp or difficulty with squatting down and standing back up. Seen in our office 10/27, 1x1.5cm area of induration with mild erythema. No sign of pain with palpation of the area. No fluctuance or purulence. Mom said the redness had decreased since 10/26.
In the evening I started to experience some chills and felt tired.  During the night I woke and felt achy in muscles and joints and had a slight headache.  In the morning I was running a slight fever (about 99.1) and was achy and had a headache.  I also felt slightly nauseous.  I took some Tylenol and felt progressively better throughout the afternoon.  At about 9pm the following evening I do not feel any of the symptoms of the prior night.
from 2:30 pm to 8pm  I had chills. and fatigue 8pm I got a low grade fever 100.8 . I was no longer getting the chills, I was hot. then came a bad headache.  The following morning I woke up no fever just a headache. the headache went away within a couple of hours. I had fatigue the rest of the day. then symptoms where all gone.
28FEB immed pain lt deltoid; 1MAR noticed localized redness & swelling; 2MAR rx Cataflam;
Subsequent to receiving vax the pt experienced what appears to be herpes zoster. The pt sought unspecified medical treatment. Additional information has been requested.
Information has been received from a 21 year old female consumer that is also the patient, who has no pertinent medical history, drug reaction/allergies or concomitant medication usage. On 05-DEC-2007, the consumer was vaccinated (route and site not reported) with the 1st dose of GARDASIL (lot# not reported). The consumer found out she was pregnant after receiving the 1st dose of GARDASIL. The consumer reported that she was 6 weeks pregnant. The patient did receive unspecified medical attention. No lab diagnostic test were performed. Follow up from the consumer indicated that she had a miscarriage on 31-JAN-2008. She added that "everything is OK now," and added that she had no problems since then. Upon internal review, had a miscarriage was considered to be serious as an other important medical event. No additional information is expected.
Fainting, weakness, difficulty breathing, entire arm swollen to the point of dimpling flesh, rash around throat and chest, shocky low body temperature for 36 hours. Gradual decrease over >3 days. Massive bruise at administration site appeared after 24 hours, doubled in size each day for three days; evidence of fresh subcutaneous bleeding continues to develop more than one week later.
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. On 13-SEP-2016, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB lot # L025738, expiration date: 14-AUG-2017, intramuscular. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of 25.7 degrees Celsius for 57 hours. Data logger was involved. There was no previous excursion reported. Additional information has been requested.
Cannot be properly communicated in this small space. Full anaph. reaction w/Dr's office 1st then ambulance, then ER.
Redness and edema with hard knot in center and hives onset within 24 hours while sleeping. Seen today 10/19/2015 @ 0845. Redness approx. 10 cm x 6 cm at this time. Client c/o itching. Caladryl lotion applied with partial relief of itching. Client reports was worse Friday and some better today.
Have not felt good since having this vaccine; having a reaction to it; A spontaneous report  was received from a female consumer who was administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced not feeling good since receiving vaccine and having a reaction to it.    The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch unknown) intramuscularly in the arm for prophylaxis of COVID-19 infection.   On 1 Jan 2020, patient reports not feeling good since receiving vaccine and having a reaction to it.    No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, not feeling good since receiving vaccine and having a reaction to it was unknown.; Reporter's Comments: This case concerns a female of unknown age who experienced NS unexpected events of malaise and an unspecified adverse event (having a reaction to it). Event onset occurred the same day as the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
fever; chills; mental disorientation; felt sick for a whole week; This is a spontaneous report from Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 22Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and patient's concomitant medications were not reported. Patient got first dose on 22Mar2021. She got side effects. she had a fever, chills, and mental disorientation. She felt sick for a whole week. she didn't know if she can go through this again. The event outcome for events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Steadily increasing myalgia, chills, headache, and fever. Highest oral temperature reading was 101.6, at about 12:30 AM, 30m after treatment with ibuprofen had begun. Temperature was normal by 11:30 AM on the 30th.
This spontaneous report as received from a licensed vocational nurse refers to unspecified number of patients of unknown age and gender. The concurrent conditions, drug reactions/allergies and medical history of the patients were not reported. On an unknown date, the patients were vaccinated with a dose of improperly stored RECOMBIVAX with either lot number M010671 with expiration date of 20-JUN-2018 or L048209 with expiration date 03-MAY-2018(strength, dose and route of administration were not reported, which was stored at 1.1 celsius degrees for 24 hours. There was no previous temperature excursion. The temperature excursions were detected by a data logger. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Pt was admitted on 2/18 due to a left femoral neck fracture. A COVID swab was taken on 2/22 due to transfer requirements to hospice care and pt was COVID positive, yet asymptomatic.
Patient fiancée stated patient passed out while driving, but regained consciousness. Patient was advised to go to nearest urgent clinic or call 911.
The Chief at facility called to report a case of Myopericarditis. The patient is an 18 y/o male who received primary SPV, AVA #1, Typhoid IM, and FLUMIST on 31 Oct 2008. He developed Flu like symptoms and chest pain requiring hospitalization on 11/29/08. Symptoms: Nausea w/ vomiting. 12/26/08-records received-chest pain. 3-3 days after vaccine C/O flu-like illness, mild headache, cough sore throat, general body achiness then would feel well and symptoms returned and included chest pain on 11/26/08. Diagnosis myocarditis, acute.